Metastatic cancer radiation therapy registry study
Part of Cancer clinical trials.
This study is a registry that collects information from people with cancer that has spread who are receiving radiation therapy as part of their usual care. By joining, you help researchers learn more about how radiation works in this setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer that has spread to other parts of the body (metastatic), or your doctor suspects it has spread.
- You are 18 years old or older.
- Your doctor has recommended radiation therapy as part of your regular cancer treatment.
- You can understand and sign a consent form, and agree to let researchers use your health information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps a registry (a record) of people with metastatic (spread) cancer who are receiving focused, high-dose radiation to body sites outside the brain. It aims to better understand outcomes and care patterns for these patients.
This registry collects information from people who have conditions that may be treated with radiation therapy (proton or standard X-ray radiation). It helps the clinic better understand patients’ care and outcomes, and joining requires signing consent.
This study keeps records to understand outcomes for people who had radiation treatment (or were evaluated for it) since 2000. It may help doctors compare results for different conditions and treatment approaches, including cancer and non-cancer problems.
This study follows people with cancer to better understand which treatments cause certain side effects when radiation is combined with targeted (molecular) medicines. Your participation may help doctors predict and manage side effects more safely in the future.
This study tests whether targeted radiation can help your immune system respond to immunotherapy again if your cancer has stopped responding. You would continue your current immunotherapy and receive a few focused radiation doses to one tumor site.
This study collects health information from patients with cancer that has spread to the liver. Researchers will track your medical history and outcomes to better understand how metastatic liver cancer develops and progresses.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.